Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02816879 · ClinicalTrials.gov registry record · NA
Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men
A NA study of HIV Infection and Human Papillomavirus Infection, sponsored by Jonsson Comprehensive Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 415
- Enrollment target
- 3
- Study locations
NCT02816879: Active NA study of HIV Infection and Human Papillomavirus Infection, sponsored by Jonsson Comprehensive Cancer Center.
NCT02816879 is a NA study of HIV Infection and Human Papillomavirus Infection that is active but no longer recruiting, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 415 participants, above the 237-participant average among 73 other HIV Infection trials with a reported enrollment target (75% higher). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02816879, a NA study of HIV Infection and Human Papillomavirus Infection, is active but no longer recruiting, sponsored by Jonsson Comprehensive Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 415 participants
- Enrollment target
- 3
- Study locations
Study Summary
This clinical trial compares three anal cytology collection procedures (collected at a single visit) in men who have sex with men (MSM). It also compares two different tests for human papilloma virus, the virus that causes high grade anal dysplasia, which is thought to occur before anal cancer. This study may help doctors develop better screening for high-grade anal dysplasia in MSM in order to identify those who need to return for additional screening and treatment.
Primary Outcome
Two contingency tables will contrast cytology classification (for each swab type) with anal intraepithelial neoplasia (AIN) diagnosis based upon high-resolution anoscopy (HRA) \& histology.
Conditions Studied
Interventions
- OTHER Laboratory Biomarker Analysis
- PROCEDURE Cytology Specimen Collection Procedure
Study Locations (3)
California
- Los Angeles Gay and Lesbian Center - Los Angeles
- UCLA / Jonsson Comprehensive Cancer Center - Los Angeles
- Desert AIDS Project - Palm Springs
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 415 participants |
| Start Date | 2013-08-01 |
| Est. Completion | 2027-06-01 |
| Phase | NA |
What the registry record for NCT02816879 still lists
NCT02816879 is an interventional study that assigns participants to a tested intervention. The registered 415 participants enrollment target is mid-sized for trials with a published cap, above the 237-participant average among 73 other HIV Infection trials with a reported enrollment target (75% higher).
The record links to 3 conditions, with HIV Infection appearing as the primary indexed condition, and to 2 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT02816879 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT02816879 about?
NCT02816879 is a clinical study titled "Anal Cytology Collection Procedures in Predicting High-Grade Anal Dysplasia in Men Who Have Sex With Men". This clinical trial compares three anal cytology collection procedures (collected at a single visit) in men who have sex with men (MSM). It also compares two different tests for human papilloma virus, the virus that causes high grade anal dysplasia, which is thought to occur before anal cancer. This...
What is the current status of trial NCT02816879?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 415 participants. The study started on 2013-08-01. Estimated completion is 2027-06-01.
What conditions does trial NCT02816879 study?
This clinical trial studies the following conditions: HIV Infection, Human Papillomavirus Infection, Anal Carcinoma.
What interventions are being tested in trial NCT02816879?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Cytology Specimen Collection Procedure (PROCEDURE).
Who is sponsoring clinical trial NCT02816879?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02816879 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02816879's enrollment target sits among peer trials
415 9th of 73 higher than 65 of 73 other HIV Infection trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other HIV Infection trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
HIV+ Deceased Donor Heart Transplant Study for HIV+ Recipients
RECRUITING · NA
-
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
RECRUITING · NA
-
Suubi-Mhealth: A Mobile Health Intervention to Address Depression Among Youth
RECRUITING · NA
-
The Role of the Gastrointestinal-associated Lymphoid Tissue in the Cure of HIV Infection
RECRUITING · NA
-
Technology-based Training Tool for PHAT Life
COMPLETED · NA
-
Physician Focused Intervention to Improve Adherence With HIV Antiretrovirals
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05142605 · 415 participants · NA
Evaluation of Grief Therapy Approaches for Bereaved Parents
- NCT03527537 · 416 participants · Phase 4
Gestational Diabetes and Pharmacotherapy (GAP)
- NCT05007782 · 416 participants · Phase 1
Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors
- NCT05520099 · 416 participants
Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI